Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention

PloS One
David CarballoBaris Gencer

Abstract

Structured secondary cardiovascular prevention programs (SSCP) following acute coronary syndromes (ACS) may reduce major adverse cardiovascular events (MACE) through better adherence to post-ACS recommendations. Through a prospective multicenter cohort study, we compared the outcomes of two sequential post-ACS patient cohorts, the initial one receiving standard care (SC) followed by one receiving additional interventions (SSCP) aimed at improving patient education as well as healthcare provider and hospital systems. The primary endpoint was MACE at one year. Secondary endpoints included adherence to recommended therapies, attendance to cardiac rehabilitation (CR) and successful achievement of cardiovascular risk factor (CVRF) targets. In total, 2498 post-ACS patients from 4 Swiss university hospitals were included: 1210 vs 1288 in the SC and SSCP groups, respectively. The SSCP group demonstrated a significant increase in attendance to CR programs (RR 1.08, 95%CI 1.02-1.14, P = 0.006), despite not achieving the primary MACE endpoint (HR 0.97, 95%CI 0.77-1.22, P = 0.79). After age-stratification, significant reductions in cardiac death, MI and stroke events (HR 0.53, 95%CI 0.30-0.93, P for interaction = 0.016) were observed for S...Continue Reading

References

Sep 4, 1999·American Journal of Public Health·R E GlasgowS M Boles
Mar 12, 2002·JAMA : the Journal of the American Medical Association·Rajendra H MehtaUNKNOWN GAP Steering Committee of the American College of Cardiology
Sep 3, 2002·Journal of the American College of Cardiology·Ira S OckeneJacqueline Dunbar-Jacob
Oct 4, 2005·Journal of the American College of Cardiology·Kim A EagleUNKNOWN American College of Cardiology Foundation (Bethesda, Maryland) Guidelines Applied in Practice Steering committee
Nov 3, 2005·Annals of Internal Medicine·Alexander M ClarkFinlay A McAlister
Mar 22, 2007·JAMA : the Journal of the American Medical Association·Ph Gabriel StegUNKNOWN REACH Registry Investigators
May 3, 2007·JAMA : the Journal of the American Medical Association·Keith A A FoxUNKNOWN GRACE Investigators
Apr 14, 2010·The Journal of Cardiovascular Nursing·Nancy Houston Miller
Oct 19, 2010·Health Research Policy and Systems·André Busato, Georg von Below
Jun 6, 2012·JAMA : the Journal of the American Medical Association·Otávio BerwangerUNKNOWN Bridge-Acs Investigators
Jul 20, 2012·Circulation. Cardiovascular Quality and Outcomes·Anne Lambert-KerznerUNKNOWN Multifaceted Intervention to Improve Cardiac Medication Adherence and Secondary Prevention Measures (Medication) Study Inves
Aug 28, 2012·European Heart Journal·Kristian ThygesenUNKNOWN ESC Committee for Practice Guidelines (CPG)
Jul 31, 2014·Journal of the American Heart Association·Sylvie S L Leung YinkoUNKNOWN GENESIS‐PRAXY investigators
Jan 15, 2015·European Journal of Internal Medicine·Baris GencerFrançois Mach

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass
ELIPS

Clinical Trials Mentioned

NCT01075867

Software Mentioned

STATA
ELIPS

Related Concepts

Related Feeds

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.